Cited by 1,137CRISPR and Genetic EngineeringDNA Repair MechanismsRNA regulation and disease

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining

Open access

Maruyama, Takeshi, Dougan, Stephanie K, Truttmann, Matthias C, Bilate, Angelina M, Ingram, Jessica R, Ploegh, Hidde L·2015·Nature Biotechnology

DOI 10.1038/nbt.3190PMC PMC4618510

Open this paper in CoChat — free account

Abstract

Methods to introduce targeted double-strand breaks (DSBs) into DNA enable precise genome editing by increasing the rate at which externally supplied DNA fragments are incorporated into the genome through homologous recombination. The efficiency of these methods is limited by nonhomologous end joining (NHEJ), an alternative DNA repair pathway that competes with homology-directed repair (HDR). To promote HDR at the expense of NHEJ, we targeted DNA ligase IV, a key enzyme in the NHEJ pathway, using the inhibitor Scr7. Scr7 treatment increased the efficiency of HDR-mediated genome editing, using Cas9 in mammalian cell lines and in mice for all four genes examined, up to 19-fold. This approach should be applicable to other customizable endonucleases, such as zinc finger nucleases and transcription activator-like effector nucleases, and to nonmammalian cells with sufficiently conserved mechanisms of NHEJ and HDR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt.3190

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Integrative genomics viewer
Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G., & Mesirov, J. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1754 · Cited by 15,390
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
Genetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering
Yang, H., Wang, H., Shivalila, C. S., Cheng, A. W., Shi, L., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.08.022 · Cited by 1,596
Double-strand break repair: 53BP1 comes into focus
Panier, S., & Boulton, S. J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3719 · Cited by 1,168
Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software
Kamentsky, L. D., Jones, T. R., Fraser, A. N., Bray, M., Logan, D. J., Madden, K. L., Ljosa, V., Rueden, C., Eliceiri, K. W., & Carpenter, A. E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr095 · Cited by 1,002

Flagged first, then by citations

Show all 32 references

Sorted by citations

Items 401–500 of 1,000

A possible aid in targeted insertion of large DNA elements by CRISPR/Cas in mouse zygotes
Nakao, H., Harada, T., Nakao, K., Kiyonari, H., Inoue, K., Furuta, Y., & Aiba, A. (2015) · genesis · doi:10.1002/dvg.22914 · Cited by 36
The expanding footprint of CRISPR/Cas9 in the plant sciences
Schaeffer, S. M., & Nakata, P. A. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1987-x · Cited by 37
CRISPR-Cas immunity, DNA repair and genome stability
Cubbon, A., Ivančić-Baće, I., & Bolt, E. L. (2018) · Bioscience Reports · doi:10.1042/bsr20180457 · Cited by 39
Functional interrogation of Lynch syndrome‐associated MSH2 missense variants via CRISPR‐Cas9 gene editing in human embryonic stem cells
Rath, A., Mishra, A., Ferreira, V. D., Hu, C., Omerza, G., Kelly, K., Hesse, A., Reddi, H. V., Grady, J. P., & Heinen, C. D. (2019) · Human Mutation · doi:10.1002/humu.23848 · Cited by 36
Enhancing site-specific DNA integration by a Cas9 nuclease fused with a DNA donor-binding domain
Ma, S., Wang, X., Hu, Y., Lv, J., Liu, C., Liao, K., Guo, X., Wang, D., Lin, Y., & Rong, Z. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa779 · Cited by 36
Microbial single-strand annealing proteins enable CRISPR gene-editing tools with improved knock-in efficiencies and reduced off-target effects
Wang, C., Cheng, J. K. W., Zhang, Q., Hughes, N. W., Xia, Q., Winslow, M. M., & Cong, L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1264 · Cited by 36
Systematically attenuating DNA targeting enables CRISPR-driven editing in bacteria
Collias, D., Vialetto, E., Yu, J., Co, K., Almási, É. D. H., Rüttiger, A.-S., Achmedov, T., Strowig, T., & Beisel, C. L. (2023) · Nature Communications · doi:10.1038/s41467-023-36283-9 · Cited by 37
HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9
Llargués‐Sistac, G., Bonjoch, L., & Castellvı́-Bel, S. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1111488 · Cited by 40
Chemical Inhibitors of Non-Homologous End Joining Increase Targeted Construct Integration in Cryptococcus neoformans
Arras, S. D. M., & Fraser, J. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163049 · Cited by 36
Nick-initiated homologous recombination: Protecting the genome, one strand at a time
Vriend, L. E. M., & Krawczyk, P. M. (2016) · DNA repair · doi:10.1016/j.dnarep.2016.12.005 · Cited by 37
DNA repair protein RAD51 enhances the CRISPR/Cas9-mediated knock-in efficiency in brain neurons
Kurihara, T., Kouyama-Suzuki, E., Satoga, M., Li, X., Badawi, M., Thiha, Baig, D. N., Yanagawa, T., Uemura, T., Mori, T., et al. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.132 · Cited by 36
Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9
Amiri, M., Moaveni, A. K., Zolbin, M. M., Shademan, B., & Nourazarian, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1462697 · Cited by 37
Use of genome-editing tools to treat sickle cell disease
Tasan, I., Jain, S., & Zhao, H. (2016) · Human Genetics · doi:10.1007/s00439-016-1688-0 · Cited by 36
CRISPR Genome Engineering for Human Pluripotent Stem Cell Research
Chaterji, S., Ahn, E. H., & Kim, D. (2017) · Theranostics · doi:10.7150/thno.18456 · Cited by 35
HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies
Liu, S., Wang, Q., Yu, X., Li, Y., Guo, Y., Liu, Z., Sun, F., Hou, W., Li, C., Wu, L. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-26894-4 · Cited by 35
Strategies for the Enrichment and Selection of Genetically Modified Cells
Ren, C., Xu, K., Segal, D. J., & Zhang, Z. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.07.017 · Cited by 35
One Cell, One Drop, One Click: Hybrid Microfluidics for Mammalian Single Cell Isolation
Samlali, K., Ahmadi, F., Quach, A. B. V., Soffer, G., & Shih, S. C. C. (2020) · Small · doi:10.1002/smll.202002400 · Cited by 36
Applications of Alternative Nucleases in the Age of CRISPR/Cas9
Guha, T. K., & Edgell, D. R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122565 · Cited by 37
Ultra-superovulation for the CRISPR-Cas9-mediated production of gene-knockout, single-amino-acid-substituted, and floxed mice
Nakagawa, Y., Sakuma, T., Nishimichi, N., Yokosaki, Y., Yanaka, N., Takeo, T., Nakagata, N., & Yamamoto, T. (2016) · Biology Open · doi:10.1242/bio.019349 · Cited by 34
Strategies for precise gene edits in mammalian cells
Fichter, K. M., Setayesh, T., & Malik, P. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.012 · Cited by 34
Functional interrogation of non-coding DNA through CRISPR genome editing
Canver, M. C., Bauer, D. E., & Orkin, S. H. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.008 · Cited by 36
CRISPR RNA-guided FokI nucleases repair a PAH variant in a phenylketonuria model
Pan, Y., Shen, N., Jung‐Klawitter, S., Betzen, C., Hoffmann, G. F., Hoheisel, J. D., & Blau, N. (2016) · Scientific Reports · doi:10.1038/srep35794 · Cited by 34
Multiplex CRISPR/Cas9-based genome engineering enhanced by Drosha-mediated sgRNA-shRNA structure
Yan, Q., Xu, K., Xing, J., Zhang, T., Wang, X., Wei, Z., Ren, C., Liu, Z., Shao, S., & Zhang, Z. (2016) · Scientific Reports · doi:10.1038/srep38970 · Cited by 33
Highly Efficient and Versatile Plasmid-Based Gene Editing in Primary T Cells
Kornete, M., Marone, R., & Jeker, L. T. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701121 · Cited by 33
Antibody discovery and engineering by enhanced CRISPR-Cas9 integration of variable gene cassette libraries in mammalian cells
Parola, C., Neumeier, D., Friedensohn, S., Csepregi, L., Tacchio, M. D., Mason, D. M., & Reddy, S. T. (2019) · mAbs · doi:10.1080/19420862.2019.1662691 · Cited by 33
DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors
Amodio, V., Vitiello, P. P., Bardelli, A., & Germano, G. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02848-8 · Cited by 33
A non-inheritable maternal Cas9-based multiple-gene editing system in mice
Sakurai, T., Kamiyoshi, A., Kawate, H., Mori, C., Watanabe, S., Tanaka, M., Uetake, R., Sato, M., & Shindo, T. (2016) · Scientific Reports · doi:10.1038/srep20011 · Cited by 32
Application of the genome editing tool CRISPR/Cas9 in non-human primates.
Luo, X., Li, M., & Su, B. (2016) · Europe PMC (PubMed Central) · doi:10.13918/j.issn.2095-8137.2016.4.214 · Cited by 32
Comparative Analysis of piggyBac, CRISPR/Cas9 and TALEN Mediated BAC Transgenesis in the Zygote for the Generation of Humanized SIRPA Rats
Jung, C., Ménoret, S., Brusselle, L., Tesson, L., Usal, C., Chenouard, V., Remy, S., Ouisse, L., Poirier, N., Vanhove, B., et al. (2016) · Scientific Reports · doi:10.1038/srep31455 · Cited by 34
Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells
Luo, Z., Gao, M., Huang, N., Wang, X., Yang, Z., Yang, H., Huang, Z., & Feng, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1229-5 · Cited by 33
CRISPR and Target-Specific DNA Endonucleases for Efficient DNA Knock-in in Eukaryotic Genomes.
Lee, S. H., Kim, S., & Hur, J. K. (2018) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2018.0408 · Cited by 32
CRISPR-Cas systems: Challenges and future prospects
Gohil, N., Bhattacharjee, G., Lam, N. L., Perli, S. D., & Singh, V. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.008 · Cited by 33
Strategies for Enhancing the Homology-Directed Repair Efficiency of CRISPR-Cas Systems
Sun, W., Liu, H., Yin, W., Qiao, J., Zhao, X., & Liu, Y. (2022) · The CRISPR Journal · doi:10.1089/crispr.2021.0039 · Cited by 33
Superior Fidelity and Distinct Editing Outcomes of SaCas9 Compared with SpCas9 in Genome Editing
Yang, Z.-X., Fu, Y.-W., Zhao, J.-J., Zhang, F., Li, S.-A., Zhao, M., Wen, W., Zhang, L., Cheng, T., Zhang, J., et al. (2022) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2022.12.003 · Cited by 32
Genome Editing for the Understanding and Treatment of Inherited Cardiomyopathies
Nguyen, Q., Lim, K. R. Q., & Yokota, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030733 · Cited by 33
CRISPR/Cas9 ribonucleoprotein-mediated knockin generation in hTERT-RPE1 cells
Ghetti, S., Burigotto, M., Mattivi, A., Magnani, G., Casini, A., Bianchi, A., Cereseto, A., & Fava, L. L. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100407 · Cited by 31
The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells
Duan, Y., Ma, G., Huang, X., D'Amore, P. A., Zhang, F., & Lei, H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.729467 · Cited by 31
In Vivo Applications of CRISPR-Based Genome Editing in the Retina
Yu, W., & Wu, Z. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00053 · Cited by 32
Ways of improving precise knock-in by genome-editing technologies
Smirnikhina, S., Anuchina, A. A., & Лавров, А. В. (2018) · Human Genetics · doi:10.1007/s00439-018-1953-5 · Cited by 32
Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development
Wang, P., Yan, F., Li, Z., Yu, Y., Parnell, S. E., & Xiong, Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129107 · Cited by 31
Genome Editing in Large Animals
West, J. D., & Gill, W. (2016) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2016.03.008 · Cited by 31
A novel technique based on in vitro oocyte injection to improve CRISPR/Cas9 gene editing in zebrafish
Xie, S., Bian, W.-P., Wang, C., Junaid, M., Zou, J., & Pei, D. (2016) · Scientific Reports · doi:10.1038/srep34555 · Cited by 31
Recruitment of DNA Repair MRN Complex by Intrinsically Disordered Protein Domain Fused to Cas9 Improves Efficiency of CRISPR-Mediated Genome Editing
Reuven, N. B., Adler, J., Broennimann, K., Myers, N., & Shaul, Y. (2019) · Biomolecules · doi:10.3390/biom9100584 · Cited by 31
Gene Therapy for Inherited Retinal Degeneration
Arbabi, A., Liu, A., & Ameri, H. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0087 · Cited by 30
The Interface of Gene Editing with Regenerative Medicine
Farag, V., Devey, E. A., & Leong, K. W. (2024) · Engineering · doi:10.1016/j.eng.2024.10.019 · Cited by 30
Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer
Shen, Y., Xu, K., Yuan, Z., Guo, J., Zhao, H., Zhang, X., Zhao, L., Qing, Y., Li, H., Pan, W., et al. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1327-0 · Cited by 30
Development of a multi-locus CRISPR gene drive system in budding yeast
Yan, Y., & Finnigan, G. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-34909-3 · Cited by 33
Genetic Transformation of Filamentous Fungi: Achievements and Challenges
Lichius, A., Moreno-Ruiz, D., & Zeilinger, S. (2020) · Grand challenges in biology and biotechnology · doi:10.1007/978-3-030-29541-7_5 · Cited by 30
Gene Editing for the Treatment of Primary Immunodeficiency Diseases
Rai, R., Thrasher, A. J., & Cavazza, A. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.185 · Cited by 30
Modulating CRISPR/Cas9 genome-editing activity by small molecules
Chen, S., Chen, D., Liu, B., & Haisma, H. J. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.018 · Cited by 32
Recent Advances in the Production of Genome-Edited Rats
Sato, M., Nakamura, S., Inada, E., & Takabayashi, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052548 · Cited by 31
CRISPR/Cas9—A Promising Therapeutic Tool to Cure Blindness: Current Scenario and Future Prospects
Ahmad, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911482 · Cited by 30
Guide Picker is a comprehensive design tool for visualizing and selecting guides for CRISPR experiments
Hough, S. H., Kancleris, K., Brody, L., Humphryes-Kirilov, N., Wolanski, J., Dunaway, K. W., Ajetunmobi, A., & Dillard, V. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1581-4 · Cited by 30
Generation of genetically-engineered animals using engineered endonucleases
Lee, J. G., Sung, Y. H., & Baek, I. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1037-z · Cited by 31
Identification and characterization of novel SCR7‐based small‐molecule inhibitor of DNA end‐joining, SCR130 and its relevance in cancer therapeutics
Ray, U., Raul, S. K., Gopinatha, V. K., Ghosh, D., Rangappa, K. S., Mantelingu, K., & Raghavan, S. C. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23186 · Cited by 30
Fluorophore‐Conjugated Holliday Junctions for Generating Super‐Bright Antibodies and Antibody Fragments
Li, Z., Theile, C. S., Chen, G., Bilate, A. M. B., Duarte, J. N., Avalos, A. M., Fang, T., Barberena, R., Sato, S., & Ploegh, H. L. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201505277 · Cited by 29
Self-citation
Modeling Dominant and Recessive Forms of Retinitis Pigmentosa by Editing Three Rhodopsin-Encoding Genes in Xenopus Laevis Using Crispr/Cas9
Feehan, J. M., Chiu, C. N., Stanar, P., Tam, B. M., Ahmed, S. N., & Moritz, O. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-07153-4 · Cited by 31
CHO Cell Line Development and Engineering via Site-specific Integration: Challenges and Opportunities
Shin, S. W., & Lee, J. S. (2020) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-020-0093-7 · Cited by 29
CRISPR-Mediated Modification of DNA Methylation Pattern in the New Era of cancer therapy
Maroufi, F., Maali, A., Abdollahpour‐Alitappeh, M., Ahmadi, M. H., & Azad, M. (2020) · Epigenomics · doi:10.2217/epi-2020-0110 · Cited by 29
Small-molecule inhibitors of histone deacetylase improve CRISPR-based adenine base editing
Shin, H. R., See, J.-E., Kweon, J., Kim, H. S., Sung, G., Park, S., Jang, A.-H., Jang, G., Choi, K., Kim, I., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab052 · Cited by 29
Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
Bhattacharjee, R., Jana, A., Nandi, A., Sinha, A., Bhattacharjee, A., Mitra, S., Kar, S., Dey, A., Singh, S. K., Varma, R. S., et al. (2022) · Materials & Design · doi:10.1016/j.matdes.2022.111415 · Cited by 29
CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
Kruminis-Kaszkiel, E., Juranek, J. K., Maksymowicz, W., & Wojtkiewicz, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030906 · Cited by 29
Generation of mouse conditional knockout alleles in one step using thei-GONAD methodPreprint
Shang, R., Zhang, H., & Bi, P. (2020) · Genome Research · doi:10.1101/gr.265439.120 · Cited by 30
New Therapeutics for Extracellular Vesicles: Delivering CRISPR for Cancer Treatment
Yan, B., & Liang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415758 · Cited by 28
Gene Therapies in Clinical Development to Treat Retinal Disorders
McClements, M. E., Elsayed, M. E. A. A., Major, L., de la Cámara, C. M.-F., & MacLaren, R. E. (2024) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-024-00722-0 · Cited by 28
Exploring CRISPR-Cas: The transformative impact of gene editing in molecular biology
Pandey, V. P., Sharma, S., & Pokharel, Y. R. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102717 · Cited by 29
Selectable One-Step PCR-Mediated Integration of a Degron for Rapid Depletion of Endogenous Human Proteins
Sheridan, R. M., & Bentley, D. L. (2016) · BioTechniques · doi:10.2144/000114378 · Cited by 28
CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy
Zhang, X., Wang, L., Liu, M., & Li, D. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9057-2 · Cited by 28
Production of knock-in mice in a single generation from embryonic stem cells
Ukai, H., Kiyonari, H., & Ueda, H. R. (2017) · Nature Protocols · doi:10.1038/nprot.2017.110 · Cited by 28
Use of two gRNAs for CRISPR/Cas9 improves bi‐allelic homologous recombination efficiency in mouse embryonic stem cells
Acosta, S., Fiore, L., Carota, I. A., & Oliver, G. C. (2018) · genesis · doi:10.1002/dvg.23212 · Cited by 28
CRISPR Craze to Transform Cardiac Biology
van Kampen, S. J., & van Rooij, E. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.06.008 · Cited by 30
Tauroursodeoxycholic acid acts via TGR5 receptor to facilitate DNA damage repair and improve early porcine embryo development
Dicks, N., Gutierrez, K., Currin, L., de Macedo, M. P., Glanzner, W. G., Michalak, M., Agellon, L. B., & Bordignon, V. (2019) · Molecular Reproduction and Development · doi:10.1002/mrd.23305 · Cited by 28
Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders
Chen, Y., Wen, R., Yang, Z., & Chen, Z. (2021) · Gene Therapy · doi:10.1038/s41434-021-00247-9 · Cited by 29
Improvement of the LbCas12a-crRNA System for Efficient Gene Targeting in Tomato
Vu, T. V., Doan, D., Tran, M. T., Sung, Y. W., Song, Y. J., & Kim, J. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.722552 · Cited by 28
eIF3a R803K mutation mediates chemotherapy resistance by inducing cellular senescence in small cell lung cancer
Chen, Y., Wang, C., Xiao, D., He, B., Li, M., Yi, X., Zhang, W., Yin, J., & Liu, Z. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105934 · Cited by 28
Targeted-Deletion of a Tiny Sequence via Prime Editing to Restore SMN Expression
Zhou, M., Tang, S., Duan, N., Xie, M., Li, Z., Feng, M., Wu, L., Hu, Z., & Liang, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147941 · Cited by 28
Impact of CRISPR/HDR editing versus lentiviral transduction on long-term engraftment and clonal dynamics of HSPCs in rhesus macaques
Lee, B., Gin, A. L., Wu, C., Singh, K., Grice, M. Z., Mortlock, R. D., Abraham, D. M., Fan, X., Zhou, Y., Aljanahi, A. A., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.02.010 · Cited by 30
Programmable Single and Multiplex Base-Editing in Bombyx mori Using RNA-Guided Cytidine Deaminases
Li, Y., Ma, S., Sun, L., Zhang, T., Chang, J., Lü, W., Chen, X., Liu, Y., Wang, X., Shi, R., et al. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200134 · Cited by 28
Genome editing in macroalgae: advances and challenges
Saeger, J. D., Vandelannoote, E. C., Lee, H., Park, J., & Blomme, J. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1380682 · Cited by 27
CRISPR activation: identifying and using novel genes for plant disease resistance breeding
McLaughlin, J. E., Foka, I. C. K., Lawton, M. A., & Di, R. (2025) · Frontiers in Genome Editing · doi:10.3389/fgeed.2025.1596600 · Cited by 28
Germline Modification and Engineering in Avian Species
Lee, H. J., Lee, H. C., & Han, J. Y. (2015) · Molecules and Cells · doi:10.14348/molcells.2015.0225 · Cited by 27
The Yin and Yang of nucleic acid-based therapy in the brain
Gustincich, S., Zucchelli, S., & Mallamaci, A. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.11.001 · Cited by 27
A comparison of CRISPR/Cas9 and siRNA-mediated ALDH2 gene silencing in human cell lines
Wang, F., Guo, T., Jiang, H., Li, R., Wang, T., Zeng, N., Dong, G., Zeng, X., Li, D., Xiao, Y., et al. (2018) · Molecular Genetics and Genomics · doi:10.1007/s00438-018-1420-y · Cited by 27
Evolution of CRISPR towards accurate and efficient mammal genome engineering
Ryu, S.-M., Hur, J. W., & Kim, K. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.8.149 · Cited by 28
A Universal Surrogate Reporter for Efficient Enrichment of CRISPR/Cas9-Mediated Homology-Directed Repair in Mammalian Cells
Yan, N., Sun, Y., Fang, Y., Deng, J., Mu, L., Xu, K., Mymryk, J. S., & Zhang, Z. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.12.021 · Cited by 29
A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa
Köcher, T., Bischof, J., Haas, S. A., March, O. P., Liemberger, B., Hainzl, S., Illmer, J., Hoog, A., Muigg, K., Binder, H., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.05.015 · Cited by 27
Precise exogenous insertion and sequence replacements in poplar by simultaneous HDR overexpression and NHEJ suppression using CRISPR-Cas9
Movahedi, A., Wei, H., Zhou, X., Fountain, J. C., Chen, Z., Mu, Z., Sun, W., Zhang, J., Li, D., Guo, B. Z., et al. (2022) · Horticulture Research · doi:10.1093/hr/uhac154 · Cited by 27
Manipulation of the Tyrosinase gene permits improved CRISPR/Cas editing and neural imaging in cichlid fish
Li, C., Steighner, J. R., Sweatt, G., Thiele, T. R., & Juntti, S. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-94577-8 · Cited by 27
Targeted genome engineering using designer nucleases: State of the art and practical guidance for application in human pluripotent stem cells
Merkert, S., & Martin, U. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.02.027 · Cited by 27
Efficient Knock-in of a Point Mutation in Porcine Fibroblasts Using the CRISPR/Cas9-GMNN Fusion Gene
Gerlach, M., Kraft, T., Brenner, B., Petersen, B., Niemann, H., & Montag, J. (2018) · Genes · doi:10.3390/genes9060296 · Cited by 27
Integration-defective lentiviral vector mediates efficient gene editing through homology-directed repair in human embryonic stem cells
Wang, Y., Wang, Y., Chang, T., Huang, H., & Yee, J.-K. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1057 · Cited by 26
Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches
Taher, M., Aminondin, S. '., Nasir, N. A., Jasmadi, N. A., Nizam, N. I. N., Shahrul, I. S., Susanti, D., Khotib, J., Faiyazuddin, M., Widodo, R. T., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1630994 · Cited by 28
Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity
Ito, Y., Ashenberg, O., Pyrdol, J. W., Luoma, A., Rozenblatt–Rosen, O., Hofree, M., Christian, E., de Andrade, L. F., Tay, R. E., Teyton, L., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180300 · Cited by 26
Self-citation
Development of CRISPR/Cas9-mediated gene disruption systems in Giardia lamblia
Lin, Z., Gan, S. W., Tung, S.-Y., Ho, C.-C., Su, L., & Sun, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213594 · Cited by 26
Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair
Kelm, J. M., Samarbakhsh, A., Pillai, A., VanderVere-Carozza, P. S., Aruri, H., Pandey, D. S., Pawelczak, K. S., Turchi, J. J., & Gavande, N. S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.850883 · Cited by 27
The evolution of CRISPR/Cas9 and their cousins: hope or hype?
Bhushan, K., Chattopadhyay, A., & Pratap, D. (2018) · Biotechnology Letters · doi:10.1007/s10529-018-2506-7 · Cited by 27
Poor Splice-Site Recognition in a Humanized Zebrafish Knockin Model for the Recurrent Deep-Intronic c.7595-2144A>G Mutation in USH2A
Slijkerman, R. W. N., Goloborodko, A., Broekman, S., de Vrieze, E., Hetterschijt, L., Peters, T. A., Gerits, M., Kremer, H., & van Wijk, E. (2018) · Zebrafish · doi:10.1089/zeb.2018.1613 · Cited by 26
RS‐1 enhances CRISPR‐mediated targeted knock‐in in bovine embryos
Lamas‐Toranzo, I., Martínez‐Moro, Á., Callaghan, E., de la Blanca, M. G. M., Sánchez, J. M., Lonergan, P., & Bermejo‐Álvarez, P. (2020) · Molecular Reproduction and Development · doi:10.1002/mrd.23341 · Cited by 29
Recent developments of tools for genome and metabolome studies in basidiomycete fungi and their application to natural product research
Alberti, F., Kaleem, S., & Weaver, J. A. (2020) · Biology Open · doi:10.1242/bio.056010 · Cited by 26
Single-step generation of homozygous knockout/knock-in individuals in an extremotolerant parthenogenetic tardigrade using DIPA-CRISPR
Kondo, K., Tanaka, A., & Kunieda, T. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011298 · Cited by 26

Authors: Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L.
Affiliations: Whitehead Institute for Biomedical Research (US)
Corresponding author: Ploegh, Hidde L
ORCID: Maruyama, Takeshi
Dougan, Stephanie K
Truttmann, Matthias C
Bilate, Angelina M
Ingram, Jessica R
Ploegh, Hidde L
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2015-03-23
Volume: 33
Issue: 5
Pages: 538-542
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.3190
PMC: PMC4618510
OpenAlex: W2008147758
Cited by: 1,137
References: 32
Citations by year: 2026: 39 · 2025: 58 · 2024: 62 · 2023: 67 · 2022: 108 · 2021: 101 · 2020: 117 · 2019: 122 · 2018: 125 · 2017: 139 · 2016: 143 · 2015: 55
FWCI: 66.47
Type: journal article
Language: en
Update notices: erratum (2016-02-05)
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
PMC
Funders: National Institute of Allergy and Infectious Diseases (R01AI087879)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords: CRISPR/Cas9, genome editing efficiency, non-homologous end joining, homology-directed repair, DNA ligase IV, DNA double-strand break repair, zinc finger nucleases, TALEN
MeSH terms: DNA Ligase ATP, Animals, Cell Line, DNA Repair, Genetic Engineering, DNA Ligases, Pyrimidines, Schiff Bases, Zinc Fingers, Genome, Mice, DNA Breaks, Double-Stranded, Homologous Recombination, DNA End-Joining Repair, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks